Zevra Therapeutics (ZVRA) Assets Growth (3y) (2017 - 2025)
Zevra Therapeutics (ZVRA) Assets Growth (3y) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 35.15% |
| Sep 30, 2025 | 31.38% |
| Jun 30, 2025 | 27.29% |
| Mar 31, 2025 | 641.33% |
| Dec 31, 2024 | 10.24% |
| Sep 30, 2024 | 11.77% |
| Jun 30, 2024 | 1.33% |
| Mar 31, 2024 | 18.71% |
| Dec 31, 2023 | 148.65% |
| Sep 30, 2023 | 131.49% |
| Jun 30, 2023 | 104.56% |
| Dec 31, 2022 | 122.25% |
| Sep 30, 2022 | 109.85% |
| Jun 30, 2022 | 112.17% |
| Mar 31, 2022 | -26.44% |
| Dec 31, 2021 | 70.66% |
| Sep 30, 2021 | 94.18% |
| Jun 30, 2021 | 59.82% |
| Mar 31, 2021 | 28.47% |
| Dec 31, 2020 | -40.22% |